Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast Cancer

Benzer Materyaller

• Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! for Women with Node-Negative, ER-Positive Breast Cancer: Results from NSABP B-14 and NSABP B-20
  Yazar:: Tang, Gong, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
  Yazar:: Mamounas, Eleftherios P., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells
  Yazar:: Chua, Boon Tin, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Neoadjuvant nab-paclitaxel in the treatment of breast cancer
  Yazar:: Ueno, Naoto T., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors
  Yazar:: Tang, Gong, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)